FASN and neoplasm: Additionally, fatty acid synthesis inhibitors like the FASN inhibitor TVB-2640 and glutathione synthesis inhibitors like BSO can reduce tumor reliance on lipids and antioxidants, improving immunotherapy efficacy [136].